JPH07500597A - 移植用細胞の冷凍方法 - Google Patents

移植用細胞の冷凍方法

Info

Publication number: JPH07500597A
Authority: JP; Japan
Prior art keywords: cells; transplantation; freezing; rate; cell viability
Prior art date: 1991-10-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP5507910A

Other languages

English (en)

Japanese (ja)

Inventor

ピーターソン　デイル　アール

ベレンソン　ロナルド　ジェイ

ゴフ　ランダル　エイ

ハイムフェルド　シェリー

トンプソン　ペニー

Original Assignee

セルプロ　インコーポレイテッド

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-10-23

Filing date

1992-10-22

Publication date

1995-01-19

1992-10-22 Application filed by セルプロ　インコーポレイテッド filed Critical セルプロ　インコーポレイテッド

1995-01-19 Publication of JPH07500597A publication Critical patent/JPH07500597A/ja

Status Pending legal-status Critical Current

Links

238000002054 transplantation Methods 0.000 title claims description 66
210000004027 cell Anatomy 0.000 claims description 220
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 81
238000000034 method Methods 0.000 claims description 54
238000007710 freezing Methods 0.000 claims description 43
230000008014 freezing Effects 0.000 claims description 43
239000000243 solution Substances 0.000 claims description 29
230000003833 cell viability Effects 0.000 claims description 20
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
238000001816 cooling Methods 0.000 claims description 18
239000000203 mixture Substances 0.000 claims description 17
238000010257 thawing Methods 0.000 claims description 15
210000003771 C cell Anatomy 0.000 claims description 12
102000004169 proteins and genes Human genes 0.000 claims description 11
108090000623 proteins and genes Proteins 0.000 claims description 11
230000003204 osmotic effect Effects 0.000 claims description 9
239000010836 blood and blood product Substances 0.000 claims description 7
229940125691 blood product Drugs 0.000 claims description 7
239000002577 cryoprotective agent Substances 0.000 claims description 7
239000002609 medium Substances 0.000 claims description 6
206010061598 Immunodeficiency Diseases 0.000 claims description 5
239000000872 buffer Substances 0.000 claims description 4
230000001225 therapeutic effect Effects 0.000 claims description 4
239000001963 growth medium Substances 0.000 claims description 3
238000000746 purification Methods 0.000 claims description 3
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 claims description 2
239000007864 aqueous solution Substances 0.000 claims description 2
230000008569 process Effects 0.000 claims description 2
239000012980 RPMI-1640 medium Substances 0.000 claims 1
238000001802 infusion Methods 0.000 claims 1
210000001185 bone marrow Anatomy 0.000 description 26
239000007788 liquid Substances 0.000 description 17
238000011084 recovery Methods 0.000 description 13
238000000926 separation method Methods 0.000 description 11
239000002245 particle Substances 0.000 description 9
210000001772 blood platelet Anatomy 0.000 description 7
238000010322 bone marrow transplantation Methods 0.000 description 7
238000002512 chemotherapy Methods 0.000 description 7
238000005138 cryopreservation Methods 0.000 description 7
239000011148 porous material Substances 0.000 description 7
230000035899 viability Effects 0.000 description 7
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
206010028980 Neoplasm Diseases 0.000 description 6
230000008901 benefit Effects 0.000 description 6
210000003743 erythrocyte Anatomy 0.000 description 6
239000012528 membrane Substances 0.000 description 6
102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 5
101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 5
239000011324 bead Substances 0.000 description 5
238000005057 refrigeration Methods 0.000 description 5
239000003381 stabilizer Substances 0.000 description 5
238000003756 stirring Methods 0.000 description 5
208000026310 Breast neoplasm Diseases 0.000 description 4
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical group OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 4
230000000735 allogeneic effect Effects 0.000 description 4
201000011510 cancer Diseases 0.000 description 4
239000006285 cell suspension Substances 0.000 description 4
239000008367 deionised water Substances 0.000 description 4
229910021641 deionized water Inorganic materials 0.000 description 4
239000012530 fluid Substances 0.000 description 4
229960002897 heparin Drugs 0.000 description 4
229920000669 heparin Polymers 0.000 description 4
238000001959 radiotherapy Methods 0.000 description 4
238000003860 storage Methods 0.000 description 4
239000000126 substance Substances 0.000 description 4
108090001008 Avidin Proteins 0.000 description 3
206010006187 Breast cancer Diseases 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
206010025323 Lymphomas Diseases 0.000 description 3
208000001647 Renal Insufficiency Diseases 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
239000006143 cell culture medium Substances 0.000 description 3
230000005779 cell damage Effects 0.000 description 3
208000037887 cell injury Diseases 0.000 description 3
230000001332 colony forming effect Effects 0.000 description 3
239000013078 crystal Substances 0.000 description 3
230000018044 dehydration Effects 0.000 description 3
238000006297 dehydration reaction Methods 0.000 description 3
201000010099 disease Diseases 0.000 description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
239000012153 distilled water Substances 0.000 description 3
239000011521 glass Substances 0.000 description 3
210000003714 granulocyte Anatomy 0.000 description 3
230000003834 intracellular effect Effects 0.000 description 3
201000006370 kidney failure Diseases 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
230000005855 radiation Effects 0.000 description 3
210000000130 stem cell Anatomy 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
206010000830 Acute leukaemia Diseases 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
239000004471 Glycine Substances 0.000 description 2
206010019233 Headaches Diseases 0.000 description 2
102000001554 Hemoglobins Human genes 0.000 description 2
108010054147 Hemoglobins Proteins 0.000 description 2
206010020772 Hypertension Diseases 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
206010047700 Vomiting Diseases 0.000 description 2
238000013019 agitation Methods 0.000 description 2
230000006793 arrhythmia Effects 0.000 description 2
206010003119 arrhythmia Diseases 0.000 description 2
210000000170 cell membrane Anatomy 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
238000011109 contamination Methods 0.000 description 2
230000000959 cryoprotective effect Effects 0.000 description 2
230000003111 delayed effect Effects 0.000 description 2
235000015872 dietary supplement Nutrition 0.000 description 2
208000002173 dizziness Diseases 0.000 description 2
230000000694 effects Effects 0.000 description 2
231100000869 headache Toxicity 0.000 description 2
238000002955 isolation Methods 0.000 description 2
208000032839 leukemia Diseases 0.000 description 2
210000000265 leukocyte Anatomy 0.000 description 2
239000003446 ligand Substances 0.000 description 2
230000000670 limiting effect Effects 0.000 description 2
238000005259 measurement Methods 0.000 description 2
230000009871 nonspecific binding Effects 0.000 description 2
239000008188 pellet Substances 0.000 description 2
230000000149 penetrating effect Effects 0.000 description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
239000001267 polyvinylpyrrolidone Substances 0.000 description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
230000004083 survival effect Effects 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
230000002588 toxic effect Effects 0.000 description 2
238000012546 transfer Methods 0.000 description 2
230000008673 vomiting Effects 0.000 description 2
108010088751 Albumins Proteins 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
206010060935 Alloimmunisation Diseases 0.000 description 1
208000032467 Aplastic anaemia Diseases 0.000 description 1
208000019838 Blood disease Diseases 0.000 description 1
208000035049 Blood-Borne Infections Diseases 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
102000013925 CD34 antigen Human genes 0.000 description 1
108050003733 CD34 antigen Proteins 0.000 description 1
GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
206010010356 Congenital anomaly Diseases 0.000 description 1
241000632511 Daviesia arborea Species 0.000 description 1
206010013975 Dyspnoeas Diseases 0.000 description 1
241000257465 Echinoidea Species 0.000 description 1
241001522296 Erithacus rubecula Species 0.000 description 1
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
229930182566 Gentamicin Natural products 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
208000029462 Immunodeficiency disease Diseases 0.000 description 1
206010058467 Lung neoplasm malignant Diseases 0.000 description 1
206010028813 Nausea Diseases 0.000 description 1
239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
206010070863 Toxicity to various agents Diseases 0.000 description 1
241000700605 Viruses Species 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
230000004520 agglutination Effects 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
238000004220 aggregation Methods 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
239000000427 antigen Substances 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
210000002960 bfu-e Anatomy 0.000 description 1
230000027455 binding Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
210000000601 blood cell Anatomy 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
210000002449 bone cell Anatomy 0.000 description 1
210000002798 bone marrow cell Anatomy 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
229940057373 c-time Drugs 0.000 description 1
230000021523 carboxylation Effects 0.000 description 1
238000006473 carboxylation reaction Methods 0.000 description 1
230000006727 cell loss Effects 0.000 description 1
230000006037 cell lysis Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
210000002791 cfu-m Anatomy 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
231100000481 chemical toxicant Toxicity 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
239000002131 composite material Substances 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000034994 death Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000000593 degrading effect Effects 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
239000012897 dilution medium Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000011067 equilibration Methods 0.000 description 1
210000003013 erythroid precursor cell Anatomy 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
231100000040 eye damage Toxicity 0.000 description 1
239000012091 fetal bovine serum Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000005189 flocculation Methods 0.000 description 1
230000016615 flocculation Effects 0.000 description 1
238000000684 flow cytometry Methods 0.000 description 1
230000004927 fusion Effects 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
229960002518 gentamicin Drugs 0.000 description 1
239000008103 glucose Substances 0.000 description 1
230000003394 haemopoietic effect Effects 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
208000014951 hematologic disease Diseases 0.000 description 1
210000003958 hematopoietic stem cell Anatomy 0.000 description 1
208000018706 hematopoietic system disease Diseases 0.000 description 1
230000006910 ice nucleation Effects 0.000 description 1
230000005965 immune activity Effects 0.000 description 1
230000028993 immune response Effects 0.000 description 1
230000007813 immunodeficiency Effects 0.000 description 1
238000011534 incubation Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
201000005296 lung carcinoma Diseases 0.000 description 1
230000000527 lymphocytic effect Effects 0.000 description 1
208000003747 lymphoid leukemia Diseases 0.000 description 1
230000003211 malignant effect Effects 0.000 description 1
239000000463 material Substances 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
208000025113 myeloid leukemia Diseases 0.000 description 1
230000008693 nausea Effects 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
-1 or preferably Substances 0.000 description 1
238000004091 panning Methods 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
210000005259 peripheral blood Anatomy 0.000 description 1
239000011886 peripheral blood Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
210000003446 pia mater Anatomy 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
239000000047 product Substances 0.000 description 1
230000002685 pulmonary effect Effects 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
238000004062 sedimentation Methods 0.000 description 1
239000007787 solid Substances 0.000 description 1
UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000013589 supplement Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000008961 swelling Effects 0.000 description 1
238000012360 testing method Methods 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
239000003440 toxic substance Substances 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
210000003462 vein Anatomy 0.000 description 1
235000021419 vinegar Nutrition 0.000 description 1
239000000052 vinegar Substances 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/16—Physical preservation processes
- A01N1/162—Temperature processes, e.g. following predefined temperature changes over time
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Dentistry (AREA)
Wood Science & Technology (AREA)
Environmental Sciences (AREA)
Immunology (AREA)
Cell Biology (AREA)
Developmental Biology & Embryology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Biotechnology (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Hematology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

JP5507910A 1991-10-23 1992-10-22 移植用細胞の冷凍方法 Pending JPH07500597A (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US78048791A	1991-10-23	1991-10-23
US780,487		1991-10-23
PCT/US1992/009023 WO1993007745A1 (fr)	1991-10-23	1992-10-22	Procede pour congeler des cellules de greffage

Publications (1)

Publication Number	Publication Date
JPH07500597A true JPH07500597A (ja)	1995-01-19

Family

ID=25119725

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP5507910A Pending JPH07500597A (ja)	1991-10-23	1992-10-22	移植用細胞の冷凍方法

Country Status (4)

Country	Link
EP (1)	EP0609379A1 (fr)
JP (1)	JPH07500597A (fr)
CA (1)	CA2122140A1 (fr)
WO (1)	WO1993007745A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2016164155A (ja) *	2015-02-26	2016-09-08	株式会社細胞応用技術研究所	多血小板血漿の保存方法
JPWO2021100829A1 (fr) *	2019-11-20	2021-05-27

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995010291A1 (fr) *	1993-10-08	1995-04-20	Cellpro Ii	Procedes de collecte et de cryoconservation de granulocytes humains
US7112576B1 (en)	1999-12-10	2006-09-26	Regents Of The University Of Minnesota	Compositions and methods for cryopreservation of peripheral blood lymphocytes
WO2002046368A1 (fr) *	2000-12-04	2002-06-13	Humantec Ltd.	Liquide de conservation de cellules et procede de conservation de cellules dans lequel ledit liquide est utilise
EP3020276B1 (fr) *	2014-11-14	2018-02-28	Milestone S.r.l.	Procédé et appareil permettant de cryoconserver des échantillons biologiques
CN108056095A (zh) *	2017-12-28	2018-05-22	重庆斯德姆生物技术有限公司	一种脂肪间充质干细胞运输保护液及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5004681B1 (en) *	1987-11-12	2000-04-11	Biocyte Corp	Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
US5061620A (en) *	1990-03-30	1991-10-29	Systemix, Inc.	Human hematopoietic stem cell

1992
- 1992-10-22 CA CA002122140A patent/CA2122140A1/fr not_active Abandoned
- 1992-10-22 EP EP92923231A patent/EP0609379A1/fr not_active Withdrawn
- 1992-10-22 JP JP5507910A patent/JPH07500597A/ja active Pending
- 1992-10-22 WO PCT/US1992/009023 patent/WO1993007745A1/fr not_active Ceased

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2016164155A (ja) *	2015-02-26	2016-09-08	株式会社細胞応用技術研究所	多血小板血漿の保存方法
JP2021073213A (ja) *	2015-02-26	2021-05-13	株式会社細胞応用技術研究所	多血小板血漿の保存方法
JPWO2021100829A1 (fr) *	2019-11-20	2021-05-27
WO2021100829A1 (fr) *	2019-11-20	2021-05-27	大日本住友製薬株式会社	Méthode de congélation de cellules neurales
JP2024097884A (ja) *	2019-11-20	2024-07-19	住友ファーマ株式会社	神経系細胞の凍結方法

Also Published As

Publication number	Publication date
CA2122140A1 (fr)	1993-04-29
WO1993007745A1 (fr)	1993-04-29
EP0609379A1 (fr)	1994-08-10

Publication	Publication Date	Title
AU693339B2 (en)	1998-06-25	Cryopreservation solution
CN101031339B (zh)	2012-07-18	将活性成份掺入红细胞的裂解/再封方法和装置
Korbling et al.	1995	Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease
Stiff et al.	1983	Unfractionated human marrow cell cryopreservation using dimethylsulfoxide and hydroxyethyl starch
Andreu et al.	1988	Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration
Takaue et al.	1989	Isolation and storage of peripheral blood hematopoietic stem cells for autotransplantation into children with cancer
Melaragno et al.	1985	Cryopreservation of Human Platelets Using 6% Dimethyl Sulfoxide and Storage at‐80°: Effects of 2 Years of Frozen Storage at‐80° C and Transportation in Dry Ice 1
JP2001518792A (ja)	2001-10-16	血液製剤から希少細胞を採集する方法
US20040152190A1 (en)	2004-08-05	Method of separating and concentrating cells for kidney regfneration
Debelak et al.	1974	Granulocyte transfusions in leukopenic dogs: in vivo and in vitro function of granulocytes obtained by continuous-flow filtration leukopheresis
CN115644168B (zh)	2024-03-01	一种成品免疫细胞的冻存液及其制备方法和冻存方法
Rowley et al.	1999	Post-thaw removal of DMSO does not completely abrogate infusional toxicity or the need for pre-infusion histamine blockade
Cannas et al.	2014	Supportive care in patients with acute leukaemia: historical perspectives
CA2397344C (fr)	2011-03-15	Compositions pour le stockage de plaquettes
WO1995010291A1 (fr)	1995-04-20	Procedes de collecte et de cryoconservation de granulocytes humains
JPH07500597A (ja)	1995-01-19	移植用細胞の冷凍方法
Becker et al.	1972	Prostaglandin E1 in preparation and storage of platelet concentrates
CN114342919B (zh)	2022-11-15	一种nk细胞保护运输液
Ahmed et al.	1991	Marrow storage techniques: a clinical comparison of refrigeration versus cryopreservation
EP0061277B1 (fr)	1986-09-03	Procédé anaérobie pour conserver du sang complet, des tissus ou des produits contenant des cellules vivantes de mammifères
US20040229205A1 (en)	2004-11-18	Compositions for the storage of platelets
KR100569609B1 (ko)	2006-05-02	세포면역치료제의 제조를 위한 림프구 장기 보관 방법
JPH0892001A (ja)	1996-04-09	細胞集団の保存方法
McCredie et al.	1978	Blood components in the care of the cancer patient
Janusz et al.	2021	Analysis of the occurrence of causes of early transfusion reactions of unknown etiology reported to the Regional Center of Blood Donation and Treatment in Katowice-the role of extracellular vesicles contained in the blood component based on a literature review